Tagista, tablets 24 mg 30 pcs

Betahistine improves microcirculation of the labyrinth, it is used in pathology of the vestibular apparatus.

The drug acts mainly on histamine H1- and H3-receptors of the inner ear and vestibular nuclei of the CNS.

With direct agonist effect on histamine H1-receptors of inner ear vessels and indirectly through effect on histamine H3-receptors it improves microcirculation and capillary permeability

and normalizes endolymph pressure in labyrinth and cochlea. At the same time, betahistine increases blood flow in the basilar artery.

It has a pronounced central effect, being an inhibitor of histamine H3-receptor nuclei of the vestibular nerve. It normalizes conduction in the neurons of the vestibular nuclei at the level of the brainstem.

The clinical manifestation of the above properties is reduction of the frequency and intensity of dizziness, decrease of tinnitus, improvement of hearing in case of its reduction.

Indications

Active ingredient

Composition

1 tablet contains

The active ingredient:

Betahistine dihydrochloride 24.0 mg;

Associates:

Cellulose microcrystalline – 64.25 mg,

Povidone (collidone 25) – 27.0 mg

Potato starch – 60.0 mg,

p> Citric acid – 6.0 mg,

Colloidal silica (aerosil), – 9.0 mg,

Talc – /8.4 mg,

Magnesium stearate – /1.35 mg.

How to take, the dosage

Interaction

Special Instructions

Synopsis

Features

Contraindications

Side effects

Overdose

Similarities